Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for AVF Patency in CKD
NCT05132712Phase 1Unknown
- Sponsor
- Armed Forces Post Graduate Medical Institute
- Start
- Oct 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of losartan (2 arms), sponsored by Armed Forces Post Graduate Medical Institute. Primary endpoint: primary patency at one year at 1 year. Status: unknown.
02
Drugs
losartan
Beyond the preview
Go deeper on NCT05132712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05132712.